Premature Atherosclerosis Associated With Monogenic Insulin Resistance

This study used a rare genetic condition as a natural model for understanding how insulin resistance accelerates atherosclerosis.

In patients with familial partial lipodystrophy caused by LMNA gene mutations — a disorder of fat distribution that produces severe insulin resistance — coronary heart disease was significantly more frequent, with several patients suffering early events before age 55, especially women. The mutation carriers’ premature disease illustrated how profoundly insulin resistance drives vascular damage.

The value is conceptual: a monogenic “experiment of nature” linking insulin resistance to early atherosclerosis, supporting the broader importance of metabolic health in cardiovascular risk. But it is a small observational study of a rare condition, far from the common pathways most patients face.

We rate the evidence limited. The sample is tiny and the population unusual; it is a useful illustration of a mechanism rather than evidence that guides general prevention.